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c l i n i c a l  c o m m e n t a r y
When faced with low-normal serum B12, 
either further evaluation  
or empiric treatment is warranted
With the advent of methylmalonic acid,  
homocysteine testing, and the proven 
efficacy of oral B12, medicine has come a 
long way from shilling tests and monthly 
intramuscular shots in the diagnosis and 
management of B12 deficiency. “Normal” 
serum B12 may not accurately reflect true 
tissue B12 stores. Therefore, if serum B12 is 
borderline low, I routinely get methylma-
lonic acid and homocysteine for patients 
in whom I need to “prove” deficiency (for 
myself, patients, or third-party agents) or 
monitor closely (ie, those with neurologic 
symptoms). 
   once deficiency is confirmed, search for 
a cause. since 1000 mcg of oral B12 treats 
nearly all causes of B12 deficiency (includ-
ing pernicious anemia and deficiency from 
gastric bypass surgery), empiric treatment 
is a reasonable alternative as long as 
serum B12 and symptoms are monitored 
for therapeutic response. Bottom line: 
since early detection and treatment could 
potentially prevent permanent neurologic 
sequelae, when faced with a low-normal 
serum B12, it should not be dismissed as 
“normal”—either further evaluation or  
empiric treatment is warranted.
Robert C. Oh, MD, MPH
Tripler army Medical Center, Honolulu, Hawaii
e v i d e n c e - b a s e d  a n s w e r
The best way to evaluate a low-normal 
B12 level is to check serum methylmalonic 
acid and homocysteine levels1 (strength of 
recommendation [sor]: B, based  
on consistent level 2 or 3 studies). Give  
1 or 2 mg of oral vitamin B12 a day  
if levels are marginally low and either  
methylmalonic acid or both methylmalonic 
acid and homocysteine are elevated  
(sor: a). 
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æ	Evidence	Summary
A low-normal B12 level is 150 to 350 pg/
mL. Levels less than 150 pg/mL indicate 
deficiency. Levels greater than 350 pg/mL 
indicate adequate B12 supply.
2
Vitamin B12 is a necessary coenzyme 
in the metabolism of methylmalonic acid 
to succinyl choline, and is also a necessary 
coenzyme with folate in the metabolism 
of homocysteine to methionine. Therefore, 
a vitamin B12 deficiency leads to elevated 
levels of unmetabolized methylmalonic 
acid and homocysteine. At a local lab the 
normal range of methylmalonic acid is 
0.00 to 0.40 umol/L, and homocysteine’s 
normal range is 4.0 to 10.0 mmol/L. Nor-
mal levels might vary by laboratory. Other 
conditions, such as renal insufficiency, may 
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also cause elevation of methylmalonic acid 
and homocysteine.3
Holotranscobalamin may become a 
first-choice assay for diagnosing early vi-
tamin B12 deficiency. Studies have shown 
that it compares favorably with current 
combined measures (B12 levels, methylma-
lonic acid, homocysteine). Like current as-
says, holotranscobalamin is also affected 
by renal function. It requires further inves-
tigation to establish relevant cutoff levels 
before it can be recommended as a diag-
nostic strategy.4 
Oral vitamin B12 at doses of 1000 to 
2000 mcg/d is a simple and cost-effective 
treatment option for any B12-deficient per-
son, and may actually be superior to in-
tramuscular replacement.5,6 A Cochrane 
Collaboration review of oral vitamin B12 
replacement found that these high doses 
seemed as effective as intramuscular vita-
min B12 in all B12-deficient patients—even 
those with pernicious anemia, Crohn’s 
disease, ileal resection, or malabsorption 
states. The authors of the review recom-
mend a “further large, pragmatic trial in a 
primary care setting” to determine wheth-
er oral vitamin B12 is effective for patients 
with major common cases of malabsorp-
tion and to provide additional evidence 
for cost effectiveness.6
Recommendations	from	Others
Current guidelines recommend giving vi-
tamin B12 if methylmalonic acid or both 
methylmalonic acid and homocysteine are 
elevated. Give folate if only homocysteine 
is elevated. Give vitamin B12 if homocyste-
ine elevation persists in spite of adequate 
folate replacement.2 
Monitor for correction of low-normal 
B12 and metabolites with follow-up blood 
test after 1 to 2 months of treatment. The 
negative predictive value of normal me-
tabolites (methylmalonic acid and homo-
cysteine) is unknown. 
Individuals with normal vitamin 
B12 levels and metabolites but significant 
B12 deficiency signs and symptoms have 
responded dramatically to B12 replace-
ment.7 Therefore, it is reasonable to treat 
and monitor for response as an alterna-
tive approach to the evaluation of a low- 
normal B12 level. Pennypacker et al
2 state 
that “the ultimate gold standard for vi-
tamin B12 deficiency may be the reduc-
tion in homocysteine and methylmalonic 
acid concentrations and improvement in 
clinical symptoms or signs in response to 
vitamin B12 treatment.”
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If serum vitamin 
B12 is low, check 
homocysteine and 
methylmalonic 
acid levels;  
monitor patients  
with neurologic 
symptoms
